Balchem logo

BCPC - Balchem News Story

$120.08 -2.6  -2.1%

Last Trade - 25/02/21

Sector
Consumer Defensives
Size
Large Cap
Market Cap £2.81bn
Enterprise Value £2.87bn
Revenue £497.7m
Position in Universe 1594th / 6709

Balchem Corporation Announces Dividend

Thu 17th December, 2020 12:00pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201217:nGNXQw0kh&default-theme=true


NEW HAMPTON, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation
(NASDAQ: BCPC) today announced that on December 16, 2020, its Board of
Directors declared a dividend on its shares of common stock equal to $0.58 per
share on the Company’s issued and outstanding Common Stock, to be payable on
January 22, 2021 to stockholders of record at the close of business on
December 28, 2020. This dividend represents an 11.5% increase over last
year’s annual dividend.

Ted Harris, Balchem’s CEO and President, said, “Balchem has a
long-standing commitment to an annual dividend and we are pleased to announce
the continuation of that commitment. This dividend represents the eleventh
consecutive increase in our annual dividend, reflecting both the consistently
outstanding financial performance the company has delivered and the Board’s
continued confidence in our long-term strategies.”

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients
that improve and enhance the health and well-being of life on the planet,
providing state-of-the-art solutions and the finest quality products for a
range of industries worldwide. The company reports three business segments:
Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products.
The Human Nutrition & Health segment delivers customized food and beverage
ingredient systems, as well as key nutrients into a variety of applications
across the food, supplement and pharmaceutical industries. The Animal
Nutrition & Health segment manufactures and supplies products to numerous
animal health markets. Through Specialty Products, Balchem provides
specialty-packaged chemicals for use in healthcare and other industries, and
also provides chelated minerals to the micronutrient agricultural market.

Forward-Looking Statements

This release contains forward-looking statements, which reflect Balchem’s
expectation or belief concerning future events that involve risks and
uncertainties. Balchem can give no assurance that the expectations reflected
in forward-looking statements will prove correct and various factors could
cause results to differ materially from Balchem’s expectations, including
risks and factors identified in Balchem’s annual report on Form 10-K for the
year ended December 31, 2019. Forward-looking statements are qualified in
their entirety by the above cautionary statement. Balchem assumes no duty to
update its outlook or other forward-looking statements as of any future date.

 Contact:  Mary Ann Brush, Executive Assistant to CEO  
           Telephone: 845-326-5600                     
           E-mail: mabrush@balchem.com                 

(https://www.globenewswire.com/NewsRoom/AttachmentNg/922857f8-0f15-4509-ae78-b26aa1b5893e)



GlobeNewswire, Inc. 2020
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.